Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dexamethasone × Endocrine × Clear all

Phase

Status

Terminated 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 326 Lymphoid 174 Other hematologic neoplasm 123 Genitourinary 21 Gastrointestinal 20 Gynecologic 13 Thoracic 12 Breast 12 Head & Neck 10 Sarcoma 9 Tumor-Agnostic 8 CNS 8 Dermatologic 7 Myeloid 5 Other solid neoplasm 4 Classical hematology 4 Other neoplasm 1 Other 1 Endocrine 1

Conditions

Pituitary Neoplasms 1 Pituitary Diseases 1

Interventions

Everolimus 28 Octreotide 13 Cisplatin 12 Sunitinib 10 Etoposide 9 Doxorubicin 8 pembrolizumab 7 pasireotide 7 lutetium Lu 177 dotatate 7 lanreotide 7 Temozolomide 7 3-Iodobenzylguanidine 7 gallium Ga 68 dotatate 6 Positron Emission Tomography Computed Tomography 6 Magnetic Resonance Spectroscopy 6 Bevacizumab 6 pazopanib 5 Surgical Procedures, Operative 5 Radiotherapy 5 Paclitaxel 5 Irinotecan 5 Fulvestrant 5 surufatinib 4 lenvatinib 4 avelumab 4 Sorafenib 4 Radiosurgery 4 Mitotane 4 Iodine-131 4 Gefitinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02084134 2018-04-11

Steroid

Washington University School of Medicine

Phase NA Completed

43 enrolled 8 charts

Pituitary Diseases, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡